Cargando…
A Glimpse in the Future of Malignant Mesothelioma Treatment
Malignant mesothelioma (MMe) is a rare neoplasm with few therapeutic options available. The landscape of effective therapy for this disease remained unchanged in the last two decades. Recently, however, the introduction of Immune Checkpoint Inhibitors (ICIs) led to small, but nevertheless, promising...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714955/ https://www.ncbi.nlm.nih.gov/pubmed/34975505 http://dx.doi.org/10.3389/fphar.2021.809337 |
_version_ | 1784624041435332608 |
---|---|
author | Pezzicoli, Gaetano Rizzo, Mimma Perrone, Martina Minei, Silvia Mutti, Luciano Porta, Camillo |
author_facet | Pezzicoli, Gaetano Rizzo, Mimma Perrone, Martina Minei, Silvia Mutti, Luciano Porta, Camillo |
author_sort | Pezzicoli, Gaetano |
collection | PubMed |
description | Malignant mesothelioma (MMe) is a rare neoplasm with few therapeutic options available. The landscape of effective therapy for this disease remained unchanged in the last two decades. Recently, however, the introduction of Immune Checkpoint Inhibitors (ICIs) led to small, but nevertheless, promising improvements. However, many efforts are still needed to radically improve the prognosis of MMe. In this review, we analyze all those therapeutic strategies for MMe that are still in a preclinical or early clinical phase of development. In particular, we focus on novel antiangiogenic drugs and their possible combination with immunotherapy. Furthermore, we describe also more complex strategies such as microRNA-loaded vectors, oncolytic viruses, and engineered lymphocytes. |
format | Online Article Text |
id | pubmed-8714955 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87149552021-12-30 A Glimpse in the Future of Malignant Mesothelioma Treatment Pezzicoli, Gaetano Rizzo, Mimma Perrone, Martina Minei, Silvia Mutti, Luciano Porta, Camillo Front Pharmacol Pharmacology Malignant mesothelioma (MMe) is a rare neoplasm with few therapeutic options available. The landscape of effective therapy for this disease remained unchanged in the last two decades. Recently, however, the introduction of Immune Checkpoint Inhibitors (ICIs) led to small, but nevertheless, promising improvements. However, many efforts are still needed to radically improve the prognosis of MMe. In this review, we analyze all those therapeutic strategies for MMe that are still in a preclinical or early clinical phase of development. In particular, we focus on novel antiangiogenic drugs and their possible combination with immunotherapy. Furthermore, we describe also more complex strategies such as microRNA-loaded vectors, oncolytic viruses, and engineered lymphocytes. Frontiers Media S.A. 2021-12-15 /pmc/articles/PMC8714955/ /pubmed/34975505 http://dx.doi.org/10.3389/fphar.2021.809337 Text en Copyright © 2021 Pezzicoli, Rizzo, Perrone, Minei, Mutti and Porta. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Pezzicoli, Gaetano Rizzo, Mimma Perrone, Martina Minei, Silvia Mutti, Luciano Porta, Camillo A Glimpse in the Future of Malignant Mesothelioma Treatment |
title | A Glimpse in the Future of Malignant Mesothelioma Treatment |
title_full | A Glimpse in the Future of Malignant Mesothelioma Treatment |
title_fullStr | A Glimpse in the Future of Malignant Mesothelioma Treatment |
title_full_unstemmed | A Glimpse in the Future of Malignant Mesothelioma Treatment |
title_short | A Glimpse in the Future of Malignant Mesothelioma Treatment |
title_sort | glimpse in the future of malignant mesothelioma treatment |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714955/ https://www.ncbi.nlm.nih.gov/pubmed/34975505 http://dx.doi.org/10.3389/fphar.2021.809337 |
work_keys_str_mv | AT pezzicoligaetano aglimpseinthefutureofmalignantmesotheliomatreatment AT rizzomimma aglimpseinthefutureofmalignantmesotheliomatreatment AT perronemartina aglimpseinthefutureofmalignantmesotheliomatreatment AT mineisilvia aglimpseinthefutureofmalignantmesotheliomatreatment AT muttiluciano aglimpseinthefutureofmalignantmesotheliomatreatment AT portacamillo aglimpseinthefutureofmalignantmesotheliomatreatment AT pezzicoligaetano glimpseinthefutureofmalignantmesotheliomatreatment AT rizzomimma glimpseinthefutureofmalignantmesotheliomatreatment AT perronemartina glimpseinthefutureofmalignantmesotheliomatreatment AT mineisilvia glimpseinthefutureofmalignantmesotheliomatreatment AT muttiluciano glimpseinthefutureofmalignantmesotheliomatreatment AT portacamillo glimpseinthefutureofmalignantmesotheliomatreatment |